MedTrace Logo

Registry of Chronic Subdural Hematoma

NCT06759428 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1500

Last updated 2025-01-07

No results posted yet for this study

Summary

The goal of this observational study is to better understand how chronic subdural hematoma (CSDH) progresses and how patients are treated and cared for. The study focuses on three main questions:

1. What are the characteristics of patients with CSDH when they are diagnosed?
2. What treatments do patients with CSDH receive?
3. What are the outcomes for patients with CSDH, including their functional ability, cognitive health, and neurological status?

Participants will receive their usual standard treatment. As part of the study, they will complete a brief telephone interview three months after their treatment.

Conditions

  • Chronic Subdural Hematoma
  • Registry

Sponsors & Collaborators

Principal Investigators

  • Ruben Dammers · Erasmus Medical Center

  • Dagmar Verbaan · Amsterdam UMC

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-01
Primary Completion
2027-10-31
Completion
2028-01-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06759428 on ClinicalTrials.gov